Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists
申请人:——
公开号:US20040180934A1
公开(公告)日:2004-09-16
Dihydropyrroloindoles and tetrahydropyridoindoles are prostaglandin receptor antagonists useful for the treatment of prostaglandin-mediated diseases such as allergic rhinitis, nasal congestion and asthma.
二氢吡咯吲啶和四氢吡咯吲啶是前列腺素受体拮抗剂,可用于治疗前列腺素介导的疾病,如过敏性鼻炎、鼻塞和哮喘。